Zusammenfassung
Bakterien können für den Menschen krankmachende (pathogene Bakterien, Infektionserreger) oder schützende Eigenschaften (apathogene und fakultativ pathogene Bakterien der Mikrobiota) haben. Der klinische Verlauf einer bakteriellen Infektionskrankheit wird von den Pathogenitätsfaktoren des Erregers und dem Infektionsabwehrpotenzial des Wirtes entscheidend beeinflusst. In diesem Kapitel werden die evolutionären und pathogenetischen Aspekte bakterieller Erreger im Kontext der Wirtsabwehrmechanismen dargestellt. Die diskutierten Konzepte und mechanistischen Prinzipien der Erregerpathogenität sollen dazu beitragen, die infektionsmedizinischen Strategien in der Diagnostik, Therapie und Prävention von Infektionskrankheiten besser zu verstehen bzw. dem neuesten Wissensstand anzupassen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Weiterführende Literatur
Ahmed N, Dobrindt U, Hacker J, Hasnain SE (2008) Genomic fluidity ande pathogenic bacteria: applications in diagnostics, epidemiology and intervention. Nat Rev Microbiol 6:387–394
Aktories K (2011) Bacterial protein toxins that modify host regulatory GTPases. Nat Rev Microbiol 9:487–498
Albert-Weissenberger C, Cazalet C, Buchrieser C (2007) Legionella pneumophila – a human pathogen that co-evolved with fresh water protozoa. Cell Mol Life Sci 64:432–448
Bhakdi S, Tranum-Jensen J (1991) Alphatoxin of Staphylococcus aureus. Microbiol Rev 55:733–751
Buffie CG, Pamer EG (2013) Microbiota-mediated colonization resistance against intestinal pathogens. Nat Rev Immunol 13:790–800
Eisenreich W, Rudel T, Heesemann J, Goebel W (2017) To eat and to be eaten: mutual metabolic adaptations of immune cells and intracellular bacterial pathogens upon infection. Front Cell Infect Microbiol 7:316
Eisenreich W, Rudel T, Heesemann J, Goebel W (2019) How viral and intracellular bacterial pathogens reprogram the metabolism of host cells to allow their intracellular replication. Front Cell Infect Microbiol 9:42
Falkow S (2004) Molecular Koch’s postulates applied to bacterial pathgenicity – a personal recollection 15 years later. Nat Rev Microbiol 2:67–72
Healy AR, Herzon SB (2017) Molecular basis of gut microbiome-associated colorectal cancer: a synthetic perspective. J Am Chem Soc 139:14817–14824
Heesemann J, Sing A, Trülzsch K (2006) Yersinia’s stratagem: targeting innate and adaptive immune defense. Curr Opin Microbiol 9:55–61
Kawai T, Akira S (2011) Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34:637–650
Kibe S, Adams K, Barlow G (2011) Diagnostic and prognostic biomarkers of sepsis in critical care. J Antimicrobiol Chemother 66(Suppl 2):ii33–ii40
Koh E-I, Henderson JP (2015) Microbial copper-binding siderophores at the host-pathogen interface. J Biol Chem 290:18967–18974
Koh E-I, Robinson AE, Bandara N, Rogers BE, Henderson JP (2017) Copper import in Escherichia coli by the yersiniabactin metallophore system. Nat Chem Biol 13:1016–1023
Korea C-G, Ghigo J-M, Beloin C (2011) The sweet connection: solving the riddle of multiple sugar-binding fimbrial adhesins in Escherichia coli. Bioessays 33:300–311
Lamkanfi M, Dixit VM (2010) Manipulation of host cell death pathways during microbial infections. Cell Host Microbe 8:44–54
Martin P, Tronnet S, Garcie C, Oswald E (2017) Interplay between siderophores and colibactin genotoxin in Escherichia coli. IUBMB 69:435–441
Medini D, Serruto D, Parkhill J, Relman DA, Donati C, Moxon R, Falkow S, Rappuoli R (2008) Microbiology in the post-genomic era. Nat Rev Microbiol 6:419–430
Montoy M, Gouanux E (2003) β-Barrel membrane protein folding and structure viewed through the lens of α-hemolysin. Biochim Biophys Acta 1609:19–27
Nathan C (2006) Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol 6:173–182
Rathinam VAK, Zhao Y, Shao F (2019) Innate immunity to intracellular LPS. Nat Immunol 20:527–533
Reinhart K, Hartog CS (2010) Biomarkers as a guide for antimicrobial therapy. Int J Antimicrob Agents 36S:S17–S21
Shanahan F, Quigley EMM (2014) Manipulation of the microbiota for treatment of IBS and IBS – challenges and controversies. Gastroenterology 146:1554–1563
Shi J, Gao W, Shao F (2017) Pyroptosis: gasdermin-mediated programmed necrotic cell death, Trends in Biochem. Sciences 42:245–254
Stecher B, Maier L, Hardt WD (2013) ‚Blooming‘ in the gut: how dysbiosis might contribute to pathogen evolution. Nat Rev Microbiol 11:277–284
Xue M et al (2019) Structure elucidation of colibactin and its DNA cross-links. Science 365:eaax2685
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature
About this chapter
Cite this chapter
Heesemann, J. (2020). Pathogenität und Virulenz. In: Suerbaum, S., Burchard, GD., Kaufmann, S.H.E., Schulz, T.F. (eds) Medizinische Mikrobiologie und Infektiologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-61385-6_3
Download citation
DOI: https://doi.org/10.1007/978-3-662-61385-6_3
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-61384-9
Online ISBN: 978-3-662-61385-6
eBook Packages: Medicine (German Language)